Theo-dur and Hyperhidrosis - a phase IV clinical study of FDA data
Summary:
Hyperhidrosis is found among people who take Theo-dur, especially for people who are male, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Theo-dur and have Hyperhidrosis. It is created by eHealthMe based on reports of 4,353 people who have side effects when taking Theo-dur from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
4,353 people reported to have side effects when taking Theo-dur.
Among them, 28 people (0.64%) have Hyperhidrosis.
What is Theo-dur?
Theo-dur has active ingredients of theophylline. It is often used in asthma. eHealthMe is studying from 4,372 Theo-dur users for its effectiveness, alternative drugs and more.
What is Hyperhidrosis?
Hyperhidrosis (abnormally increased sweating) is found to be associated with 3,535 drugs and 3,388 conditions by eHealthMe.
Number of Theo-dur and Hyperhidrosis reports submitted per year:

Time on Theo-dur when people have Hyperhidrosis *:
- < 1 month: 33.33 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 33.33 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 33.33 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Hyperhidrosis when taking Theo-dur *:
- female: 47.83 %
- male: 52.17 %
Age of people who have Hyperhidrosis when taking Theo-dur *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 4.35 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 26.09 %
- 50-59: 43.48 %
- 60+: 26.09 %
Common drugs people take besides Theo-dur *:
- Vioxx: 10 people, 35.71%
- Naproxen: 10 people, 35.71%
- Prednisone: 9 people, 32.14%
- Claritin: 9 people, 32.14%
- Lipitor: 8 people, 28.57%
- Paxil: 8 people, 28.57%
- Fosamax: 8 people, 28.57%
- Oxycontin: 7 people, 25.00%
- Gabapentin: 7 people, 25.00%
- Xalatan: 7 people, 25.00%
Common side effects people have besides Hyperhidrosis *:
- Breathing Difficulty: 16 people, 57.14%
- Nausea And Vomiting: 15 people, 53.57%
- Chest Pain: 15 people, 53.57%
- Pain: 13 people, 46.43%
- Diarrhea: 12 people, 42.86%
- Weakness: 12 people, 42.86%
- Nausea (feeling of having an urge to vomit): 12 people, 42.86%
- Headache (pain in head): 12 people, 42.86%
- Fatigue (feeling of tiredness): 10 people, 35.71%
- Hypoaesthesia (reduced sense of touch or sensation): 10 people, 35.71%
Common conditions people have *:
- Pain: 9 people, 32.14%
- Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 4 people, 14.29%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 7.14%
- Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 7.14%
- Type 2 Diabetes: 1 person, 3.57%
- Diabetes: 1 person, 3.57%
- Bone Density Decreased: 1 person, 3.57%
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 3.57%
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 1 person, 3.57%
- Coagulation Time Shortened: 1 person, 3.57%
* Approximation only. Some reports may have incomplete information.
Do you take Theo-dur and have Hyperhidrosis?
Check whether Hyperhidrosis is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Korang-Yeboah M, Rahman Z, Shah D, Mohammad A, Wu S, Siddiqui A, Khan MA, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International journal of pharmaceutics, 2016 Feb .
- Dhaval MK, "Impact of formulation and process variables on solid-state stability of theophylline in controlled release formulations", International Journal of Pharmaceutics, 2016 Jan .
Related studies
How severe was Hyperhidrosis and when was it recovered:
Expand to all the drugs that have ingredients of theophylline:
- Hyperhidrosis and drugs with ingredients of theophylline (209 reports)
Alternative drugs to, pros and cons of Theo-dur:
- Theo-dur (4,372 reports)
Common Theo-dur side effects:
- Asthma: 473 reports
- Breathing difficulty: 320 reports
- Pneumonia: 316 reports
- Fever: 298 reports
- Chest pain: 226 reports
- Drug ineffective: 219 reports
- Weakness: 218 reports
Browse all side effects of Theo-dur:
a b c d e f g h i j k l m n o p q r s t u v w x y zHyperhidrosis treatments and more:
- Hyperhidrosis (128,577 reports)
COVID vaccines that are related to Hyperhidrosis:
- Hyperhidrosis in Moderna COVID Vaccine
- Hyperhidrosis in Pfizer BioNTech Covid Vaccine
- Hyperhidrosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Hyperhidrosis:
- Cymbalta: 6,010 reports
- Aspirin: 5,851 reports
- Prednisone: 4,736 reports
- Metformin: 4,623 reports
- Humira: 4,043 reports
- Omeprazole: 3,678 reports
- Lyrica: 3,554 reports
- Lisinopril: 3,306 reports
- Gabapentin: 3,222 reports
- Methotrexate: 2,898 reports
All the drugs that are associated with Hyperhidrosis:
- Hyperhidrosis (3,535 drugs)
Common conditions associated with Hyperhidrosis:
- Depression: 8,339 reports
- Pain: 7,651 reports
- High blood pressure: 5,912 reports
- Rheumatoid arthritis: 5,394 reports
- Multiple sclerosis: 4,454 reports
- Stress and anxiety: 4,178 reports
- Type 2 diabetes: 3,651 reports
- High blood cholesterol: 3,184 reports
All the conditions that are associated with Hyperhidrosis:
- Hyperhidrosis (3,388 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on theophylline (the active ingredients of Theo-dur) and Theo-dur (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Humira and Epstein-Barr Virus Infection - 6 seconds ago
- Loss Of Libido in Escitalopram, how severe and when it was recovered? - 35 seconds ago
- Veletri and Insomnia - 43 seconds ago
- Colchicum and Joint Pain - 47 seconds ago
- Carac and Insomnia - 48 seconds ago
- Oregano Oil and Metronidazole drug interaction - 50 seconds ago
- Allopurinol and Quinine drug interaction - a minute ago
- Morphine and Quinine drug interaction - a minute ago
- Lunesta and Egrifta drug interaction - a minute ago
- Vimpat and Fluid Retention - a minute ago